ARCHIVES

VEGF Levels Can Predict Tumor’s Resistance to Avastin

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

October 28, 2005

NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.

May 4, 2001

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

Nexavar Improves PFS In Phase III Trial

January 25, 2013

FTC Cigarette Test Should Be Broadened, Cancer Panel Finds

December 16, 1994

Researchers Identify Mutation Linked to Inherited Risk of ALL

September 27, 2013